Who invested in Vanqua Bio?
Vanqua Bio's investors include Omega Funds, OrbiMed, Eli Lilly, Casdin Capital and Osage University Partners, and 4 more on record.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$130Mraised across 2 rounds since 2021, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $45M sold, first sale Feb 2024
Reported by Firms' own news pagesSEC filing: $85M sold, first sale Aug 2021
From Vanqua Bio's own website: 4 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Vanqua Bio's investors include Omega Funds, OrbiMed, Eli Lilly, Casdin Capital and Osage University Partners, and 4 more on record.
Vanqua Bio has raised $130M across 2 rounds since 2021.
Vanqua Bio's most recent round was a Venture of $45M in Jul 2024.
Vanqua Bio's largest round on record is $85M (Series B), in Sept 2021, led by Omega Funds.
Vanqua Bio's first round on record, in Sept 2021, was backed by Omega Funds, OrbiMed and Eli Lilly and 6 others.
Vanqua Bio's latest named round is a Venture, in Jul 2024.
Vanqua Bio is based in the United States.
Omega Funds led the Series B in 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.